Drugs / Acetyl-Leucine
Acetyl-Leucine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07275749 Comparator | Dec 2025 → Jul 2026 overdue | ischemic stroke | Kafrelsheikh University | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acetyl-Leucine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07275749 ↗ |
| Known as | Acetileucina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1875805 ↗ |
| Known as | Acetylleucine, dl- | ChEMBL registry synonym — accepted as the source's own label CHEMBL1875805 ↗ |
| Known as | NSC-122020 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1875805 ↗ |
| Known as | NSC-758152 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1875805 ↗ |
| Known as | Tanganil | ChEMBL registry synonym — accepted as the source's own label CHEMBL1875805 ↗ |
| Modality | Small molecule | — CHEMBL1875805 ↗ |